biologic

Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent

Influenza Virus Vaccine

Loss of exclusivityDecember 2021projected — 12-year biologic exclusivity estimate
CompanySanofi Vaccines US Inc.

Drug detail

Brand nameFluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent
Active ingredientInfluenza Virus Vaccine
Strength180 UG/.5ML
Dosage formInjection
RouteIntramuscular
ModalityBiologic
FDA approvalDecember 2009
Marketing statusRx

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent patent cliff — loss of exclusivity December 2021 | CliffBio